Tetra Bio-Pharma Inc.
TBP
株式のランク
#35468
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
株価
$0.01851783
最終同期: 2023-05-23
時価総額
$3.71M
変化（1日）
-0.04%
変化（1年）
1,443.15%
国
CA
取引 Tetra Bio-Pharma Inc. (TBP)
カテゴリー
Healthcare
の時価総額 Tetra Bio-Pharma Inc.(TBP)
時価総額: $3.71M
October 2026時点で、Tetra Bio-Pharma Inc. の時価総額は $3.71M です。これは、当社のデータによると、Tetra Bio-Pharma Inc. が世界で35468th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Tetra Bio-Pharma Inc. の時価総額の履歴（2011 から 2026 まで）
TBP最も人気のあるトップ5と比較stocks
